GlassScriptPhysician profile
Jamal D Farhan
NPI 1982633707
$27,380.93
in general payments reported to CMS, 2019-2025
16 companies · $1,660 in 2025
The $1,660 reported for 2025 was more than what 77% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $2,320 · 2021: $166 · 2022: $511 · 2023: $87.73 · 2024: $4,017 · 2025: $1,660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,045 · Travel and Lodging: $1,126 · Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,045.25 |
| Travel and Lodging | $1,125.78 |
| Food and Beverage | $593.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $23,727.00 | 2019-2025 | |
| Medical Device Business Services, INC. | $1,801.25 | 2020 | |
| Covidien LP | $448.50 | 2019-2020 | |
| Ethicon US, LLC | $406.72 | 2019-2024 | Echelon Endopath, Echelon; Endopath, Echelon Circular |
| Astrazeneca Pharmaceuticals LP | $256.51 | 2020-2024 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.50 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $124.99 | 2022 | |
| Davol INC. | $102.09 | 2019 | |
| Baxter Healthcare | $95.36 | 2021-2023 | Peri-Strips Dry |
| Teleflex LLC | $53.62 | 2025 | Barrigel |
| Integra Lifesciences Corporation | $45.94 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Medtronic, INC. | $45.30 | 2023 | Signia |
| Heron Therapeutics, INC. | $27.45 | 2022 | |
| W. L. Gore & Associates, INC. | $21.18 | 2025 | Gore Synecor Preperitoneal Biomaterial |
| Merck Sharp & Dohme LLC | $19.85 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $17.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamal Farhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.